SCHEDULE: Clever Way Global, Lu Yang Report Stake in Universe Pharmaceuticals

Clever Way Global Limited and Lu Yang have jointly filed a Schedule 13G, reporting beneficial ownership of 9.96% of Universe Pharmaceuticals INC's Class A ordinary shares.

Summary

• Clever Way Global Limited, a company wholly owned and controlled by Lu Yang, has reported beneficial ownership of 498,922 Class A ordinary shares of Universe Pharmaceuticals INC.
• This holding represents 9.96% of the total outstanding Class A ordinary shares.
• The filing is made under Schedule 13G, indicating that the reporting persons are not acting as a group and do not intend to influence or change the control of the issuer.
• The total number of outstanding Class A ordinary shares as of July 27, 2026, was 5,008,313.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without disclosing new financial performance or strategic shifts.

Positives

• The filing clearly discloses a significant ownership stake, providing transparency to the market.
• The reporting persons are not seeking to influence or change control of the company, suggesting a passive investment approach.

Negatives

• The filing does not provide any information on the company's financial performance, strategic direction, or operational updates.
• The ownership stake is close to the 10% threshold, which may attract further scrutiny depending on future actions.

Risks

• While not explicitly stated as a risk in this filing, any significant shift in beneficial ownership could potentially lead to changes in the company's shareholder base and governance.
• The filing does not provide forward-looking statements, leaving the market to speculate on the intentions behind this ownership stake.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Management Comments

• Clever Way Global Limited and Lu Yang certify that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors or individuals acquiring a significant, but typically passive, stake in a public company. This filing indicates a notable ownership position in Universe Pharmaceuticals INC, but without further context on the company's performance or the investor's strategy, its broader implications remain unclear.

Stakeholder Impact

• Shareholders: Increased transparency regarding a significant ownership stake, though the passive nature of the filing suggests no immediate change in control or strategy.
• Management: May need to monitor the intentions of this significant shareholder, even if currently passive.

Next Steps

• Monitor future filings from Clever Way Global Limited and Lu Yang for any changes in beneficial ownership or stated intentions.
• Observe Universe Pharmaceuticals INC's subsequent disclosures for any strategic responses or commentary related to this ownership change.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, Universe Pharmaceuticals, Clever Way Global Limited, Lu Yang, Class A ordinary shares, Ownership Stake